arrow
D

Daniel P. Nussbaum

Duke University School of Medicine
H指数:30
被引数:2,775

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

ASO Visual Abstract: Social Vulnerability as a Neighborhood-Level Determinant of Pancreatic Cancer Survivorship: A National Analysis of Veterans Affairs Patients

ASO视觉摘要:社会脆弱性作为社区层面的胰腺癌生存率决定因素:一项针对退伍军人事务部患者的全国性分析

2025-09-170
PRE
ASO Visual Abstract: ctDNA as a Novel Prognostic Biomarker of Therapeutic Efficacy in Patients with Unresectable Colorectal Liver Metastases Treated with Hepatic Arterial Infusion

ASO视觉摘要:ctDNA作为不可切除性结直肠癌肝转移患者经肝动脉灌注治疗疗效的新型预后生物标志物

2025-07-220
PRE
ASO Visual Abstract: Perioperative and Oncologic Outcomes of Hepatic Arterial Infusion Pump Chemotherapy for Patients with Unresectable Colorectal Liver Metastases at an Expanding Hai Program
2025-01-020
PRE
Genome-Derived Ampullary Adenocarcinoma Classifier and Postresection Prognostication
2024-12-011
PRE
Perioperative and Oncologic Outcomes of Hepatic Arterial Infusion (HAI) Pump Chemotherapy for Patients with Unresectable Colorectal Liver Metastases at an Expanding HAI Program
2024-11-203
PRE
Single-cell and spatial analysis of the immune landscape unveils a subset of potentially tumor-reactive T cells in patients with localized PDAC
2024-09-150
PRE
A window-of-opportunity trial using neoadjuvant hepatic artery chemotherapy for patients with localized pancreas cancer: Interim analysis of safety and feasibility
2024-09-150
PRE
Interobserver Variability in the International Study Group for Pancreatic Surgery (ISGPS)-Defined Complications After Pancreatoduodenectomy

国际胰腺外科研究组 (ISGPS) 定义的胰十二指肠切除术后并发症的观察者间差异

2024-08-010
PRE
Are enhanced recovery protocols after pancreatoduodenectomy still efficient when applied in elderly patients? A systematic review and individual patient data meta-analysis
2024-01-291
PRE
ASO Visual Abstract: Comparing Survival After Resection, Ablation, and Radiation in Small Intrahepatic Cholangiocarcinoma
2023-08-030
PRE